Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2707]
News [7018]
Articles [265]
Editorials [8]
Conferences [213]
elearning [41]
NSABP FB-7: Neoadjuvant therapy with neratinib plus trastuzumab in locally...
Dr Samuel Jacobs - NSABP Foundation, Pittsburgh, USA
NSABP FB-7: Neoadjuvant therapy with neratinib plus trastuzumab in locally advanced HER2-positive breast cancer ( Dr Samuel Jacobs - NSABP Foundation, Pittsburgh, USA )
17 Dec 2015
HER2 status as predictive marker for aromatase inhibitor versus tamoxifen use...
Dr John Bartlett - Ontario Institute for Cancer Research, Toronto, Canada
HER2 status as predictive marker for aromatase inhibitor versus tamoxifen use in early breast cancer ( Dr John Bartlett - Ontario Institute for Cancer Research, Toronto, Canada )
17 Dec 2015
Homologous recombination deficiency predicts neo-adjuvant chemotherapy response...
Dr Virginia Kaklamani - UT Health Science Center, San Antonio, TX
Homologous recombination deficiency predicts neo-adjuvant chemotherapy response in triple-negative breast cancer ( Dr Virginia Kaklamani - UT Health Science Center, San Antonio, TX )
17 Dec 2015
TAILORx: Genomic test helps identify low-risk women who do not need chemotherapy
Dr Virginia Kaklamani - UT Health Science Center, San Antonio, TX
TAILORx: Genomic test helps identify low-risk women who do not need chemotherapy ( Dr Virginia Kaklamani - UT Health Science Center, San Antonio, TX )
17 Dec 2015
Efficacy and gene expression results from eribulin SOLTI1007 neoadjuvant study
Dr Javier Cortes - Vall d´Hebron Institute of Oncology, Barcelona, Spain
Efficacy and gene expression results from eribulin SOLTI1007 neoadjuvant study ( Dr Javier Cortes - Vall d´Hebron Institute of Oncology, Barcelona, Spain )
17 Dec 2015
Editor's choice for December 2015
Prof Gordon McVie - ecancer Editor
Editor's choice for December 2015 ( Prof Gordon McVie - ecancer Editor )
16 Dec 2015
Novel estrogen receptor-targeting agent represents ‘quantum leap’
Dr Ganesh Raj - UT Southwestern Medical Center, Dallas, USA
Novel estrogen receptor-targeting agent represents ‘quantum leap’ ( Dr Ganesh Raj - UT Southwestern Medical Center, Dallas, USA )
15 Dec 2015
Higher local recurrence after skin-sparing than simple mastectomy for DCIS
Prof Nigel Bundred, University of Manchester, Manchester, United Kingdom
Higher local recurrence after skin-sparing than simple mastectomy for DCIS ( Prof Nigel Bundred, University of Manchester, Manchester, United Kingdom )
14 Dec 2015
Peri-operative lapatinib has profound antiproliferative effect in early breast...
Prof Nigel Bundred - University of Manchester, Manchester, United Kingdom
Peri-operative lapatinib has profound antiproliferative effect in early breast cancer ( Prof Nigel Bundred - University of Manchester, Manchester, United Kingdom )
14 Dec 2015
Guidelines and management of advanced breast cancer in limited resource settings
Prof Nagi S. El Saghir - American University of Beirut, Beirut, Lebanon
Guidelines and management of advanced breast cancer in limited resource settings ( Prof Nagi S. El Saghir - American University of Beirut, Beirut, Lebanon )
14 Dec 2015
New developments and technologies in hereditary cancer
Dr Johnathan Lancaster - Chief Medical Officer of Myriad Genetics, Salt Lake...
New developments and technologies in hereditary cancer ( Dr Johnathan Lancaster - Chief Medical Officer of Myriad Genetics, Salt Lake City, USA )
14 Dec 2015
Results of the CREATE-X trial
Dr Masakazu Toi - Kyoto University, Kyoto, Japan
Results of the CREATE-X trial ( Dr Masakazu Toi - Kyoto University, Kyoto, Japan )
14 Dec 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation